189 related articles for article (PubMed ID: 24893994)
1. Candesartan cilexetil microemulsions for transdermal delivery: formulation, in-vitro skin permeation and stability assessment.
Malakar J; Basu A; Nayak AK
Curr Drug Deliv; 2014; 11(3):313-21. PubMed ID: 24893994
[TBL] [Abstract][Full Text] [Related]
2. Development and in vitro/in vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil.
AboulFotouh K; Allam AA; El-Badry M; El-Sayed AM
Eur J Pharm Sci; 2017 Nov; 109():503-513. PubMed ID: 28889028
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug.
Sezgin-Bayindir Z; Antep MN; Yuksel N
AAPS PharmSciTech; 2015 Feb; 16(1):108-17. PubMed ID: 25204859
[TBL] [Abstract][Full Text] [Related]
4. Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation.
Paudel A; Ameeduzzafar ; Imam SS; Fazil M; Khan S; Hafeez A; Ahmad FJ; Ali A
Curr Drug Deliv; 2017; 14(7):1005-1015. PubMed ID: 28034361
[TBL] [Abstract][Full Text] [Related]
5. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
6. Use of compounded dispersing media for extemporaneous pediatric syrups with candesartan cilexetil and valsartan.
Musko M; Sznitowska M
Acta Pharm; 2014 Dec; 64(4):463-74. PubMed ID: 25531786
[TBL] [Abstract][Full Text] [Related]
7. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
8. The effect of polysorbate 20 on solubility and stability of candesartan cilexetil in dissolution media.
Hoppe K; Sznitowska M
AAPS PharmSciTech; 2014 Oct; 15(5):1116-25. PubMed ID: 24871550
[TBL] [Abstract][Full Text] [Related]
9. Formulation of microemulsion systems for dermal delivery of silymarin.
Panapisal V; Charoensri S; Tantituvanont A
AAPS PharmSciTech; 2012 Jun; 13(2):389-99. PubMed ID: 22350738
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of sinomenine microemulsion and its transdermal absorption].
Zhang XZ; Zhu HD; Meng SF; Pan XG
Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2007-10. PubMed ID: 18161292
[TBL] [Abstract][Full Text] [Related]
11. DEVELOPMENT OF SOLID LIPID NANOCARRIERS FOR ORAL DELIVERY OF CANDESERTAN CILEXETIL.
Ugurlu T; Nalbantoglu A; Sengel-Turk CT
Acta Pol Pharm; 2016 Nov; 73(6):1631-1638. PubMed ID: 29634119
[TBL] [Abstract][Full Text] [Related]
12. Development of microemulsions of suitable viscosity for cyclosporine skin delivery.
Benigni M; Pescina S; Grimaudo MA; Padula C; Santi P; Nicoli S
Int J Pharm; 2018 Jul; 545(1-2):197-205. PubMed ID: 29698819
[TBL] [Abstract][Full Text] [Related]
13. Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation.
Surampalli G; Nanjwade BK; Patil PA; Chilla R
Drug Deliv; 2016 Sep; 23(7):2124-2138. PubMed ID: 25080228
[TBL] [Abstract][Full Text] [Related]
14. Oral bioavailability and intestinal absorption of candesartan cilexetil: role of naringin as P-glycoprotein inhibitor.
Gurunath S; Nanjwade BK; Patil PA
Drug Dev Ind Pharm; 2015 Jan; 41(1):170-6. PubMed ID: 24168234
[TBL] [Abstract][Full Text] [Related]
15. Solid self-microemulsifying formulation for candesartan cilexetil.
Nekkanti V; Karatgi P; Prabhu R; Pillai R
AAPS PharmSciTech; 2010 Mar; 11(1):9-17. PubMed ID: 20013081
[TBL] [Abstract][Full Text] [Related]
16. [Water in oil microemulsions containing NaCl for transdermal delivery of fluorouracil].
Xiao YY; Liu F; Chen ZP; Ping QN
Yao Xue Xue Bao; 2011 Jun; 46(6):720-6. PubMed ID: 21882535
[TBL] [Abstract][Full Text] [Related]
17. Microemulsion systems to enhance the transdermal permeation of ivermectin in dogs: A preliminary in vitro study.
Machado M; Dantas IL; Galvão JG; Lima AD; Gonsalves JKMDC; Almeida EDP; de Araujo GRS; Leal LB; Sarmento VHV; Nunes RS; Lira AAM
Res Vet Sci; 2020 Dec; 133():31-38. PubMed ID: 32920349
[TBL] [Abstract][Full Text] [Related]
18. Adapalene microemulsion for transfollicular drug delivery.
Bhatia G; Zhou Y; Banga AK
J Pharm Sci; 2013 Aug; 102(8):2622-31. PubMed ID: 23728912
[TBL] [Abstract][Full Text] [Related]
19. Comparative Pharmaceutical Evaluation of Candesartan and Candesartan Cilexetil: Physicochemical Properties, In Vitro Dissolution and Ex Vivo In Vivo Studies.
Amer AM; Allam AN; Abdallah OY
AAPS PharmSciTech; 2018 Feb; 19(2):661-667. PubMed ID: 28948575
[TBL] [Abstract][Full Text] [Related]
20. Cremophor RH40-PEG 400 microemulsions as transdermal drug delivery carrier for ketoprofen.
Ngawhirunpat T; Worachun N; Opanasopit P; Rojanarata T; Panomsuk S
Pharm Dev Technol; 2013; 18(4):798-803. PubMed ID: 22023398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
